ArticleJournal of education and health promotion2025
Prevalence of restless leg syndrome and cutaneous manifestations among nondialysis dependent chronic kidney disease patients.
Article in Journal of education and health promotion, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRestless legs syndrome (RLS) is a neurological condition characterized by feelings of unpleasant sensations in limbs. RLS in patients with chronic kidney disease has substantial effect on quality of life. Chronic kidney disease (CKD) patients can also present with various cutaneous manifestations which can be helpful in early diagnosis of CKD. This study was conducted to assess the prevalence of cutaneous manifestations and RLS among nondialysis CKD patients. MATERIALS AND
methodsThe descriptive cross-sectional study was conducted on 200 CKD patients presenting in nephrology outpatient of a hospital in Pakistan from June 10, 2024, to November 10, 2024. Data were collected using structured questionnaire. RLS was diagnosed using the International Restless Legs Syndrome Study Group criteria, and sleep quality was assessed using the Pittsburgh Sleep Quality Index. Skin manifestations were diagnosed by qualified dermatologist. Data were analyzed using SPSS version 25 (SPSS, Inc., Chicago, IL, USA). The Chi-square test was used to assess significant differences among groups.
resultsRLS was reported among 34 (17%) of nondialysis CKD patients. Almost half of RLS patients 19 (55.88%) were categorized as suffering from moderate degree of RLS. It was more prevalent among women 23 (24.46%), diabetics 21 (23.07%) and patients with advance kidney disease 13 (stage V = 37.14%). Skin manifestations were observed among 121 (60.5%) participants. Commonly reported manifestations were pallor (73.55%), xerosis (66.11%), and fungal infections (63.63%).
conclusionsRLS is a considerable problem in nondialysis CKD patients and cutaneous abnormalities are frequently observed in these patients. Female gender, diabetes and advanced CKD stage make the patients more susceptible to RLS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.